By: TOMI KILGORE/EMMA COURT – August 17, 2016 The day that StemCells Inc. entered a merger that sent its stock rocketing up sevenfold (albeit to $2.36 per share), the company’s chief executive and chief financial officers effectively resigned, as did three members of the company’s board of directors. The reverse-merger with Israeli private company Microbot Medical Ltd. […]